Parallel Development of Novel Vaccine Vectors (pilot study)

Download PDF

The report describes the results from a pilot study examining the use of an attenuated strain of infectious laryngotracheitis virus (ILTV, gallid herpesvirus 1) as a vector to express antigen from infectious bronchitis virus (IBV). This work was undertaken to assess the feasibility of using this attenuated ILTV strain as a vaccine vector.

Want to be notified of similar content?